期刊文献+

甘氨酸类化合物对PPARα及γ亚型的激活作用 被引量:3

Activation of series of chemical Glycine compounds to PPARα and/or PPARγ
暂未订购
导出
摘要 目的利用适于PPAR转录激活效应检测的细胞模型,分析系列化合物对PPARα及γ亚型的活化作用。方法将PPARα(或PPARγ)表达质粒、报告基因质粒和内参照质粒共转染HepG2细胞,并以仅转染报告基因质粒和内参照质粒的细胞作为对照。5个化合物(LTD-1,3,4,6,7)分别以不同浓度作用于转染细胞24h,然后裂解细胞,测定细胞内报告基因质粒的荧光素酶活性,后者表示化合物对PPARα(或PPARγ)的激活强度。结果细胞模型稳定可靠,能够灵敏反映PPAR的特异激活效应。甘氨酸类化合物的检测表明,LTD-4、LTD-6、LTD-7均具有激活PPARα和PPARγ的双重效应,LTD-1则仅能激活PPARγ,而LTD-3对PPARα和PPARγ均无明显的激活作用。结论所建细胞模型适于PPARα和PPARγ转录激活作用的分析,化合物LTD-4,6,7具有激活PPARα和PPARγ的双重作用,为作为双激动剂先导化合物的深入研发提供了依据。 Aim To establish a screening system based on the engineered cells for identifying the synthesized compounds, which activated both the peroxisome prolif- erators activated receptor (PPAR) α and γ subtypes. Methods When HepG2 cells reached the exponential growth period, pSGS-PPARα or pSGS-PPARγ, pGL3- PPRE and pRL-TK were co-transfected into HepG2 cell according to the manufacture's protocol. Meanwhile, the cells nontransfected with pSGS-PPARα or pSGS-PPARγ were served as the control. The cells were separately stimulated by five synthesized chemical Glycine compounds (LTD-1,3,4,6 and 7) at different concentrations for 24 hrs. Then the fluorescent poten-cies of the stimulated cells were measured with Veritas microplate luminometer. Results The screening sys- tem was reliable and sensitive to reflect the activation of PPARs. It was indicated that LTD-4, LTD-6 and LTD-7 could activate both PPARα and PPARγ, of which LTD-7 was the most potent, while LTD-1 could only activate PPARγ and LTD-3 could not activate PPARα or PPARγ. Conclusions Among the com- pounds, LTD-4,6,7 exerted their dual effect on PPARα and PPARγ transactivation. Furthermore, LTD-7 was the best candidate for PPARα and PPARγ dual agonist.
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第6期787-791,共5页 Chinese Pharmacological Bulletin
基金 军事医学科学院创新启动基金资助项目(NoYC0216)
关键词 PPARΑ PPARΓ 双重激动剂 荧光素酶 PPARα PPARγ dual agonist luciferase
  • 相关文献

参考文献15

二级参考文献96

共引文献56

同被引文献44

  • 1李金鸣,常天辉,孙晓东,郝丽英,王玉萍,于艳凤,张克义.白花前胡甲素对豚鼠心肌细胞钙电流的影响(英文)[J].中国药理学报,1994,15(6):525-527. 被引量:6
  • 2Rodriguez-Calvo R, Serrano L, Coil T, et al. Activation of peroxisome proliferator-activated receptor 13/8 (PPAR β/δ ) inhibits LPS-induced cytokine production in adipocytes by lowering NF-κB activity via ERK1/2 [ J]. Diabetes ,2008,57 ( 8 ) :2149 - 57.
  • 3Ruan X,Zheng F, Guan Y. PPARs and the kidney in metabolic syndrome [ J ]. Am J Physiol Renal Physiol, 2008,294 ( 5 ) : F1032 -47.
  • 4Barish G D,Atkins A R,Downes M,et al. PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis [ J ]. Proc Natl Acad Sci USA ,2008,105( 11 ) :4271 -6.
  • 5Takata Y, Liu J, Yin F, et al. PPARδ-mediated antiinflammatory mechanisms inhibitangiotensin Ⅱ -accelerated atherosclerosis [ J ]. Proc Natl Acad Sci USA ,2008,105( 11 ) :4277 -82.
  • 6Fan Y, Wang Y ,Tang Z, et al. Suppression of pro-inflammatory adhesion molecules by PPAR-deha in human vascular endothelial cells [ J ]. Arterioscler Thromb Vasc Biol, 2008,28 ( 2 ) : 315 - 21.
  • 7Chen C, Shah Y M, Morimura K, et al. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis [ J ]. Cell Metab, 2008,7 ( 2 ) : 135 - 47.
  • 8Hollingshead H E, Morimura K, Adachi M, et al. PPARβ/δprotects against experimental colitis through a ligand-independent mechanism[ J]. Dig. Dis. Sci,2007,52( 11 ) :2912 -9.
  • 9Lee J W, Bajwa P J,Carson M J,et al. Fenofibrate represses interleukin-17 and interferon-γ expression and improves colitis in interleukin-10-deficient mice [ J ]. Gastroenterology, 2007,133 ( 1 ) : 108 - 23.
  • 10Yue T L, Nerurkar S S, Bao W, et al. In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/repeffusion injury in Zucker fatty rats [ J ]. J Pharmacol Exp Ther,2008,325 ( 2 ) :466 - 74.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部